Evidence map›Paper›PMID 29548991›Full record

ArticleThe American journal of pathology2018

Cellular and Metabolic Basis for the Ichthyotic Phenotype in NIPAL4 (Ichthyin)-Deficient Canines.

Elizabeth A Mauldin, Debra Crumrine, Margret L Casal, Sekyoo Jeong, Lukáš Opálka, Katerina Vavrova, Yoshikazu Uchida, Kyungho Park, Brittany Craiglow, Keith A Choate and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Effects of omega-Journal of lipid research · 2020
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 4 countries.

Elizabeth A MauldinDepartment of Dermatopathology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Debra CrumrineDermatology Service, Veterans Affairs Medical Center, San Francisco, California; Department of Dermatology, University of California, San Francisco, San Francisco, California.
Margret L CasalDepartment of Dermatopathology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Sekyoo JeongDepartment of BioCosmetics, Seowon University, Cheongju, South Korea.
Lukáš OpálkaDepartment of Pharmacy, Charles University, Hradec Kralove, Czech Republic.
Katerina VavrovaDepartment of BioCosmetics, Seowon University, Cheongju, South Korea; Department of Pharmacy, Charles University, Hradec Kralove, Czech Republic.
Yoshikazu UchidaDermatology Service, Veterans Affairs Medical Center, San Francisco, California; Department of Dermatology, University of California, San Francisco, San Francisco, California.
Kyungho ParkDermatology Service, Veterans Affairs Medical Center, San Francisco, California; Department of Dermatology, University of California, San Francisco, San Francisco, California.
Brittany CraiglowDepartment of Pharmacy, Charles University, Hradec Kralove, Czech Republic; Department of Dermatology, Genetics, and Pathology, Yale University, New Haven, Connecticut.
Keith A ChoateDepartment of Pharmacy, Charles University, Hradec Kralove, Czech Republic; Department of Dermatology, Genetics, and Pathology, Yale University, New Haven, Connecticut.
Kyong-Oh ShinCollege of Pharmacy, Chungbuk Natl University, Cheongju, South Korea.
Yong-Moon LeeCollege of Pharmacy, Chungbuk Natl University, Cheongju, South Korea.
Gary L GroveDepartment of Research and Development, cyberDERM, Media, Pennsylvania.
Joan S WakefieldDermatology Service, Veterans Affairs Medical Center, San Francisco, California; Department of Dermatology, University of California, San Francisco, San Francisco, California.
Denis KhnykinDepartment of Pathology, Oslo University Hospital, Oslo, Norway.
Peter M EliasDermatology Service, Veterans Affairs Medical Center, San Francisco, California; Department of Dermatology, University of California, San Francisco, San Francisco, California. Electronic address: peter.elias@ucsf.edu.
University of California, San Francisco · USCharles University · CZChungbuk National University · KRSeowon University · KRUniversity of Pennsylvania · USOslo University Hospital · NOYale University · US

Funding

Referral Ctr-Animal models of human genetic diseaseP40OD010939 · OD · UNIVERSITY OF PENNSYLVANIA · PI CASAL, MARGRET L · 2012 to 2023
$7.9M
Genetics and Pathobiology of Disorders of KeratinizationR01AR068392 · NIAMS · YALE UNIVERSITY · PI KEITH A CHOATE · 2015 to 2026
$5.7M
Pathogenesis and Therapy of Ichthyosis in Disorders of Lipid MetabolismR01AR061106 · NIAMS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MAURO, THEODORA M · 2012 to 2022
$3.3M
NIAMS NIH HHS R01 AR061106NIAMS NIH HHS R01 AR068392NIH HHS P40 OD010939
6 · The paper itself

Abstract

Mutations in several lipid synthetic enzymes that block fatty acid and ceramide production produce autosomal recessive congenital ichthyoses (ARCIs) and associated abnormalities in permeability barrier homeostasis. However, the basis for the phenotype in patients with NIPAL4 (ichthyin) mutations (among the most prevalent ARCIs) remains unknown. Barrier function was abnormal in an index patient and in canines with homozygous NIPAL4 mutations, attributable to extensive membrane stripping, likely from detergent effects of nonesterified free fatty acid. Cytotoxicity compromised not only lamellar body secretion but also formation of the corneocyte lipid envelope (CLE) and attenuation of the cornified envelope (CE), consistent with a previously unrecognized, scaffold function of the CLE. Together, these abnormalities result in failure to form normal lamellar bilayers, accounting for the permeability barrier abnormality and clinical phenotype in NIPA-like domain-containing 4 (NIPAL4) deficiency. Thus, NIPAL4 deficiency represents another lipid synthetic ARCI that converges on the CLE (and CE), compromising their putative scaffold function. However, the clinical phenotype only partially improved after normalization of CLE and CE structure with topical ω-O-acylceramide because of ongoing accumulation of toxic metabolites, further evidence that proximal, cytotoxic metabolites contribute to disease pathogenesis.

Indexed as

Disease Models, AnimalMutationAdultAnimalsDogsEpidermisFemaleHomozygoteHumansIchthyosisLipidsMalePedigreePhenotypeReceptors, Cell SurfaceLipidsNIPAL4 protein, humanReceptors, Cell Surface

Identifiers

PMID29548991
PMCPMC5971224
OpenAlexW2791167712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.